Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Vitamin D3 with FOLFOX + Bevacizumab in Metastatic Colorectal Cancer
NCT01198548Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Aug 2010
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in metastatic colorectal cancer (mCRC), sponsored by Roswell Park Comprehensive Cancer Center. Started Aug 2010; status: terminated.
02
Drugs
vitamin d
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01198548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198548.